Binding to opiate receptors in the CNS alters perception and response to pain which causes generalized CNS depression. Produces antipyresis and binds to opiate receptors in the CNS, altering perception and response to pain. Read more
[Controlled Substances] An analgesic combined opioid which blocks pain perception in the cerebral cortex by binding to opiate receptors in the CNS. Binding inhibits the flow of pain sensations and peripherally blocks pain impulses as synthesis of prostaglandins in the central nervous system is inhibited. Produces antipyresis and binds to opiate receptors in the CNS, altering perception and response to pain. Read more
[Controlled Substances] (Apo-Tramadol/Acet®, Tramacet®) is not a controlled substance but has been included here because it contains Tramadol, a non-federally regulated opioid analgesic that appears to have a reduced addictive potential.
Acetaminophen and Tramadol is an analgesic, opioid combination medication. Tramadol is more potent than codeine and most closely resembles the opiates. Read more
[Section 1.1] (Voltaren®) is a non-steroidal anti-inflammatory (NSAID) with analgesic and antipyretic properties. While the mechanism of action is not fully understood, it is known to inhibit COX-1 and COX-2 enzymes, which results in decreased formation of prostaglandin precursors. It is commonly used post-surgically for pain relief and inflammation. Read more
[Section 1.1] Neuraminidase inhibitors anti-viral agents oseltamivir (Tamiflu®) and zanamivir (Relenza®) are moderately effective for the treatment of infections with susceptible viruses of influenza strains including H1N1. More safety data is available on oseltamivir than zanamivir in pregnancy. Thus oseltamivir is the treatment of choice for the prevention and treatment of influenza. Oseltamivir reduces the spread of influenza by blocking the action of the enzyme neuraminidase and prevents the spread of virus from cell to cell reducing the duration and severity of symptoms particularly when treatment is initiated early after onset of symptoms. The neuraminidase inhibitors also reduce the duration of shedding and viral titer. Read more